Cholinergic Antagonists: all 1,354 studies that test it
Page 13 of 14. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- A Study of Oxybutynin for the Treatment of Urge Urinary IncontinenceCompletedNCT00749632Phase 2
- The Pathophysiology of Orthostatic HypotensionCompletedNCT00748059Phase 1
- Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive BladderCompletedNCT00746681Phase 2
- Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) PatientsCompletedNCT00730535Phase 4
- Anticholinergic Burden in SchizophreniaTerminatedNCT00715377Not applicable
- Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke PatientsWithdrawnNCT00713921Early Phase 1
- Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy SubjectsCompletedNCT00703703Phase 1
- A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive BladderCompletedNCT00699049Phase 4
- TC-5214 as add-on the Treatment of Major Depressive DisorderCompletedNCT00692445Phase 2
- Tiotropium and Salmeterol PK Study in COPD PatientsCompletedNCT00673478Phase 3
- A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.CompletedNCT00671216Phase 1
- Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mgCompletedNCT00650481Phase 1
- Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mgCompletedNCT00649727Phase 1
- Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mgCompletedNCT00649259Phase 1
- Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mgCompletedNCT00649129Phase 1
- Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mgCompletedNCT00648843Phase 1
- Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor OveractivityCompletedNCT00648310Phase 2/3
- A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic MonitoringCompletedNCT00646880Phase 3
- Pain Control in Renal ColicCompletedNCT00646061Phase 1
- A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.CompletedNCT00645281Phase 4
- Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisCompletedNCT00629642Phase 4
- Use of Atropine in Tredmill Stress TestingCompletedNCT00623207Phase 3
- Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGFCompletedNCT00607750Phase 2
- Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway HyperresponsivenessCompletedNCT00605410Phase 4
- Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary IncontinenceCompletedNCT00603343Phase 3
- A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria LesionsCompletedNCT00600847Phase 4
- Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)CompletedNCT00598611Phase 3
- Flexible Dose Titration Add-on Study to Treat Major Depressive DisorderCompletedNCT00593879Phase 2
- Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's DiseaseWithdrawnNCT00584090Phase 4
- Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma TherapyCompletedNCT00575523Phase 4
- Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT00568503Phase 1
- Effect of GSK1160724 In Healthy VolunteersCompletedNCT00555022Phase 1
- The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive BladderCompletedNCT00553657Phase 1
- Optimising the Propranolol Block ModelCompletedNCT00549120Phase 1
- Tiotropium for Smoking Asthmatics StudyWithdrawnNCT00546234Phase 4
- Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00545311Phase 1
- Study of Myopia Prevention in Children With Low Concentration of AtropineStatus unknownNCT00541177Phase 4
- Pharmacodynamic Trial on Rocuronium in Obese PatientsCompletedNCT00540085Phase 4
- Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)CompletedNCT00536692Phase 2
- Pharmacological vs Surgical Treatment for Mixed IncontinenceWithdrawnNCT00523068Phase 4
- Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive BladderCompletedNCT00512785Phase 3
- A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPHCompletedNCT00510406Phase 2
- A Study To Test The Interaction of Two Medications for Treatment of Overactive BladderCompletedNCT00501267Phase 1
- Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705CompletedNCT00500461Phase 1
- Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine DependenceStatus unknownNCT00495183Phase 4
- Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent PatientsCompletedNCT00495092Phase 2/3
- Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.CompletedNCT00481728Phase 1
- A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy VolunteersCompletedNCT00475436Phase 1
- Effects of Exendin(9-39) on Gastroduodenal MotilityCompletedNCT00468091Phase 1
- Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder SymptomsCompletedNCT00463541Phase 3
- Myopia Control by Combining Auricular Acupoint and Atropine EyedropsCompletedNCT00457717Phase 1
- A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)CompletedNCT00454896Phase 3
- Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive BladderCompletedNCT00454740Phase 3
- A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.CompletedNCT00453687Phase 1
- Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)CompletedNCT00440739Phase 4
- ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)TerminatedNCT00439192Phase 2
- Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00435760Phase 3
- Airway Responses to Montelukast and Desloratadine.CompletedNCT00424580Not applicable
- Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00422604Phase 2
- Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy SubjectsCompletedNCT00413790Phase 4
- Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy SubjectsCompletedNCT00413426Phase 1
- Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During ExerciseCompletedNCT00412204Phase 4
- Effects Of Detrol LA On Memory And Cognition In Elderly PopulationCompletedNCT00411437Phase 4
- The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term PregnanciesCompletedNCT00409890Phase 2
- Effect of Tiotropium on Inflammation and Exacerbations in COPDCompletedNCT00405236Phase 4
- Tiotropium + Procaterol vs Tiotropium + Placebo in COPD PatientsTerminatedNCT00394485Phase 4
- Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)CompletedNCT00391820Phase 2
- Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.CompletedNCT00388882Phase 4
- Treatment of Clozapine-Induced Hypersalivation Ipratropium BromideCompletedNCT00381589Not applicable
- Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00376714Phase 2
- Effects of Transdermal Scopolamine on Occupational PerformanceCompletedNCT00374478Phase 2
- Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung DiseaseCompletedNCT00371527Not applicable
- Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In ChildrenStatus unknownNCT00371124Phase 2/3
- A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder PatientsCompletedNCT00368706Phase 3
- Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive BladderCompletedNCT00366002Phase 4
- An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent AsthmaCompletedNCT00365560Phase 2
- SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT00361959Phase 4
- Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?WithdrawnNCT00348166Phase 1
- The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic UrticariaStatus unknownNCT00346606Phase 4
- An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.CompletedNCT00338624Phase 3
- A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)CompletedNCT00337558Phase 4
- Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00335621Phase 4
- A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.CompletedNCT00333112Phase 4
- Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy SubjectsCompletedNCT00332137Phase 2
- Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical TrialCompletedNCT00327730Phase 3
- "Death Rattle" - A Double Blind, Randomly Controlled, Crossover TrialTerminatedNCT00320892Not applicable
- Nicotinic Receptor Augmentation of SSRI AntidepressantsCompletedNCT00319319Phase 2
- Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment OutcomeStatus unknownNCT00313924Phase 4
- A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)CompletedNCT00311844Phase 4
- A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPDCompletedNCT00308191Phase 3
- Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary IncontinenceCompletedNCT00304499Phase 3
- Systematic Early Use of Neuromuscular Blocking Agents in ARDS PatientsCompletedNCT00299650Phase 4
- Ipratropium Spray for Drooling Saliva in Parkinson's DiseaseCompletedNCT00296946Phase 2
- Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive BladderCompletedNCT00293839Phase 3
- Drotaverine in Dysmenorrhoea TreatmentTerminatedNCT00292747Phase 4
- A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00292448Phase 2
- Detrol LA In Men With Overactive Bladder.CompletedNCT00282932Phase 4
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00281567Phase 3
- Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00279019Phase 1
- Spiriva® Assessment of FEV1 (SAFE)CompletedNCT00277264Phase 3